RBP7 and breast cancer: Kaplan–Meier survival analysis was performed with the GSE20685 (Figure 2(d)) and GSE42568 (Figure 2(e)) datasets from the GEO database to evaluate the prognostic value of RBP7 in breast cancer, which showed that lower expression of RBP7 was associated with a poorer prognosis in breast cancer.